Bo Ying, Abogen CEO (Xi'an Jiaotong-Liverpool University)
August 19, 2021 10:25 AM EDTUpdated 10:48 AM
Financing
China
Coronavirus

Chi­na's Abo­gen, a small mR­NA up­start, sets a biotech record with mam­moth $700M Se­ries C

Max Gelman

Senior Editor

A lit­tle-known start­up from Chi­na shocked the biotech world Thurs­day with a record-break­ing Se­ries C, show­ing how deep-pock­et­ed in­vestors are an­gling to get a piece …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Min­neso­ta 340B rev­enue dri­ven by hos­pi­tals and high-priced drugs, first state re­port says

A service from the Financial Times